This study is for frail-intermediately fit newly diagnosed multiple myeloma patients. Your current lab values will be used to determine if you qualify for this study. This study compares different chemo regimens to determine the effectiveness of them.
Contact phoneCarolyn Krahulik | 517.364.2811
Principal investigatorDr. Gordan Srkalovic, MD, PhD
Trial SubCategoryMultiple Myeloma